Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSAReal-world evidence of PYLARIFY’s effectiveness in ...

WVU Medicine St. Joseph’s Hospital is proud to announce the addition of two cutting-edge imaging services: PET/CT and ...

Credit: Getty Images The 2024 US Prostate Cancer Conference published 34 consensus ... According to the panel, PSMA PET/CT should be the preferred imaging approach for BCR. In patients who have ...

Artificial intelligence start-up Quibim has raised $50 million in first-round financing to support the rollout of its ...

Discover how AI is transforming urological cancer care with improved diagnosis, personalized treatments, and enhanced patient ...

Potential Impact on Bone Scan Guidelines Lesion Detection and Interobserver Agreement with Advanced Image Reconstruction for 18F-DCFPyL PET/CT in Patients with Biochemically Recurrent Prostate Cancer ...

The AI in Cancer Diagnosis Market growth is driven by technological advancements, rising cancer incidence, and increasing demand for early detection solutions.Pune, Jan. 23, 2025 (GLOBE NEWSWIRE) -- ...

Several ASX companies understand the importance of early detection and treatment of cancer and are working to improve ...

The firm will use the funds to further develop its AI-driven image analysis solutions, which extract actionable information from CT, PET, and MRI scans.

N.M. Virani Wockhardt Hospitals Launches URJA a Cutting-Edge LINAC Technology for Advanced Cancer Treatment in Saurashtra ...

Learn more about whether Integra LifeSciences Holdings Corporation or Lantheus Holdings, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

15, 2025 — Patients with a common aggressive type of bladder cancer ... prostate cancer may be more advanced than previously ... Artificial Intelligence: Algorithms Improve Medical Image Analysi ...